The programme of managed ambulatory rehabilitation for patients after heart valve defect surgery

Česká verze

Authors: S. Nehyba ¹; V. Chaloupka ¹; R. Souček ¹; Š. Chaloupková ²; R. Vysoký ²; F. Štětka ³; E. Skřičková ³
Authors place of work: Interní kardiologická klinika Lékařské fakulty MU a FN Brno, pracoviště Bohunice, přednosta prof. MU Dr. Jindřich Špinar, CSc., FESC ¹; Rehabilitační oddělení FN Brno, pracoviště Bohunice, přednostka prim. MU Dr. Jana Roubalová ²; Centrum kardiovaskulární a transplantační chirurgie Brno, ředitel doc. MU Dr. Petr Němec, CSc. ³
Published in the journal: Vnitř Lék 2009; 55(12): 1118-1125
Category: Původní práce

Summary

The aim of our research was to evaluate the impact of 8‑week comprehensive rehabilitation programme on circulatory parameters, left ventricular (LV) function and functional capacity of patients after aortal (ao) and mitral (mi) heart defect surgery. Patient sample and methodology: The rehabilitation programme was completed by 54 patients (exercising, RHB+) following valve defect surgery (13 women/ 41 men), aged 27– 83 (56 ± 16) years. The majority were patients with aortal (ao) stenosis (39), the remainder had a combined ao defect (7), ao regurgitation (3) or mitral (mi) regurgitation (5). Myocardial revascularisation was concomitantly performed in 18 patients. There were 18 patients in the control group (non‑exercising, RHB– ). Patients from both groups were assessed before and after the rehabilitation with exercise echocardiography and spiroergometry to the individual maximum. The intervention group underwent the managed rehabilitation programme. The control group exercised individually. Results: Reduction of the heart rate (HR) values at rest and on exercise and of the systolic and diastolic blood pressure (sBP, dBP) was observed in the exercising group. However, these changes were not statistically significant. The systolic, diastolic and global LV function parameters showed improvement although, once again, not statistically significant. Highly significant improvement in exercise tolerance (1.41 W/ kg before and 1.67 W/ kg after, p < 0.01) and peak oxygen consumption (20.0 ml/ min/ kg before and 23.6 ml/ min/ kg after, p < 0.01) were observed in the exercising patients. Improvement in functional and aerobic capacity in the control group was not statistically significant. The resting and exercise parameters (SF, sBP, dBP) have not changed either. Conclusion: The ambulatory rehabilitation programme was associated with improvement in circulatory response to exercise together with reduction in resting and exercise SF, sBP a dBP values. Tendency towards improvement in systolic, diastolic and global LV function parameters was observed even though not statistically significant in our sample. Unlike control group, the exercising group showed significant increase in exercise tolerance and aerobic capacity (p < 0.01). Managed rehabilitation programme enabled evaluation of the outcomes of the surgery, better education of the patients and optimal adjustment of pharmacotherapy, the anticoagulation treatment in particular. We did not observe any adverse reactions or other complications associated with the exercise.

Key words:
valve defects – exercise tolerance – aerobic capacity – left ventricular function – lifestyle changes

Zdroje

1. Stewart KJ, Badenhop, D, Brubaker, PH et al. Cardiac rehabilitation following percutaneous revascularisation, heart transplant, heart valve surgery, and for chronic heart failure. American college of chest physicians. Chest 2003; 123: 2104– 2111.

2. Balady GJ, Ades PA, Comoss P et al. Core components of cardiac rehabilitation/ secondary prevention programs: a statement for healthcare professionals from the American heart association and the American association of cardiovascular and pulmonary rehabilitation writing group. Circulation 2000; 102: 1069– 1073.

3. Tavazzi L et al. Task force of the working group on cardiac rehabilitation of the European society of cardiology 1992. Long‑term comprehensive care of cardiac patiens – recommendations by the Working group on rehabilitation of the ESC. Cardiac rehabilitation: definition and goals. Eur Heart J 1992; 13 (Suppl C): 1– 45.

4. Gohlke H, Gohlke‑Bärwolf C. Cardiac rehabilitation. Eur Heart J 1998; 19: 1004– 1010.

5. Paffenbarger RS, Hyde RT, Wing AL et al. The Association of changes in physical‑activity level and other life style characteristics with mortality in men. N Eng J Med 1993; 328: 538– 545.

6. Blair SN, Kohl HW, Barlow CE et al. Changes in physical fitness and all cause mortality: A prospective study of healthy and unhealthy men. JAMA 1995; 273: 1093– 1098.

7. Chaloupka V, Elbl L, Nehyba S et al. Vliv rehabilitačního programu na prognózu nemocných po infarktu myokardu. Cor Vasa 2004; 46: 29– 35.

8. Chaloupka V, Elbl L, Nehyba S et al. Pohybová aktivita u nemocných s kardiovaskulárním onemocněním. Kardiol Rev 2003; 1: 16– 20.

9. Fletcher GF, Balady G, Froelicher VF et al. Exercise standards – a statement for health care Professional from the American Heart Association. Circulation 1995; 91: 580– 615.

10. O’Connor GT, Buring JE, Yusuf S et al. An overview of randomized trials of rehabilitation with exercise after myocardial infarction. Circulation 1989; 80: 234– 244.

11. Oldridge NB, Guyatt GHH, Fischer ME et al. Cardiac rehabilitation after myocardial infarction. Combined experience of randomized clinical trials. JAMA 1988; 260: 945– 950.

12. Gohlke‑Bärwolf C, Gohlke H, Samek L et al. Exercise tolerance and working capacity after valve replacement. J Heart Valve Dis 1992; 1: 189– 195.

13. Belardinelli R, Georgiou D, Cianci G et al. Randomized, controlled trial of long‑term moderate exercise training in chronic heart failure: effects on functional capacity, quality of life, and clinical outcome. Circulation 1999; 99: 1173– 1182.

14. Sire S. Physical training and occupational rehabilitation after aortic valve replacement. Eur Heart J 1987; 8: 1215– 1220.

15. Jairath N, Salerno T, Chapman J et al. The effect of moderate exercise training on oxygen uptake post‑aortic/ mitral valve surgery. J Cardiopulm Rehabil 1995; 15: 424– 430.

16. Meurin P, Iliou MCh, Driss AB et al. Early exercise training after mitral valve repair. A multicentric prospective French study. Chest 2005; 128: 1638– 1644.

17. Butchart EG, Gohlke‑Bärwolf C, Antunes MJ et al. A on behalf of the working groups on valvular heart disease, thrombosis, and cardiac rehabilitation and exercise physiology, European society of cardiology. Recommendations for the management of patients after heart valve surgery. Eur Heart J 2005; 26: 2463– 2471.

18. Čerbák R et al. Nejčastější chlopenní vady. Aortální stenóza a mitrální regurgitace. Praha: Galén 2008.

19. Carstens V, Behrenbeck DW, Hilger HH. Exercise capacity before and after cardiac valve surgery. Cardiology 1983; 70: 41– 49.

20. Chaloupka V, Elbl L, Nehyba S. Silový trénink u nemocných po infarktu myokardu. Vnitř Lék 2000; 46: 829– 834.

21. Elbl L, Chaloupka V, Nehyba S et al. Význam kombinovaného rehabilitačního programu u nemocných s chronickou ischemickou chorobou srdeční. Vnitř Lék 2005; 51: 741– 748.

22. Chaloupka V, Elbl L. Rehabilitace po infarktu myokardu. Kardiol Rev 2005; 7: 187– 190.

23. Nehyba S, Chaloupka V, Elbl L. Rehabilitační péče o nemocné po prodělaném srdečním infarktu. Prakt Lék 1995; 6: 272– 273.

24. Bonow RO, Carabello BA, Chatterjee K et al. ACC/ AHA 2006 Practice guidelines for the management of patiens with valvular heart disease: executive summary. J Am Coll Cardiol 2006; 48: 598– 673.

25. Chaloupka V, Siegelová J, Špinarová L et al. Rehabilitace u nemocných s kardiovaskulárním onemocněním. Doporučené postupy v kardiologii. Cor Vasa 2006; 48: Kardio: K127– K135.

26. Karel I, Bukatová L, Zeleňák J et al. Časná lázeňská rehabilitace nemocných po kardiochirurgických výkonech. Cor Vasa 2006; 48: 312– 316.

27. Svačinová H, Siegelová J, Dobšák P et al. Diferencovaný přístup k preskripci fyzické aktivity u nemocných s dysfunkcí levé komory srdeční. Vnitř Lék 2008; 54: 53– 61.

28. Svačinová H, Nováková M, Placheta Z et al. Benefit of combined cardiac rehabilitation on exercise capacity and cardiovascular parameters in patients with type 2 diabetes. Tohoku J Exp Med 2008; 215: 103– 111.

29. Svačinová H. Pohybová léčba u pacientů s metabolickým syndromem. Vnitř Lék 2007; 53: 540– 544.

30. Chaloupka V, Elbl L, Nehyba S et al. Vliv rehabilitace na vrcholovou spotřebu kyslíku u nemocných po infarktu myokardu léčených beta‑blokátory. Vnitř Lék 2008; 54: 225– 228.

31. Karel I, Skalická H. Kardiovaskulární rehabilitace v současnosti. Vnitř Lék 2009; 55: 22– 26.